Michael G. White, MD, MS

Assistant Professor, Director of Research
Department of Colon and Rectal Surgery, University of Texas MD Anderson Cancer Center
Houston, Texas, United States

Dr. Michael G. White is an Assistant Professor within the Department of Colon & Rectal Surgery and a faculty member within the Transcend Cancer Initiative at the University of Texas MD Anderson Cancer Center. He has clinical expertise in the surgical management of peritoneal metastases of colorectal origin including cytoreductive surgery and heated intraperitoneal chemotherapy. His translational research interest revolve about the role of the tumor microenvironment and the role of microbial agents in altering responses to immuno and cytotoxic therapies.

Presentation(s):

• PPS16. Risk of Ovarian Metastasis in Colorectal Cancer-Related Carcinomatosis

  Thursday, March 5, 2026
  10:00 AM - 10:30 AM MST

• PPS18. Evaluating Peritoneal Washing Supernatant NGS Integration to Inform Staging of Peritoneal Metastases

  Thursday, March 5, 2026
  10:00 AM - 10:30 AM MST

• PPS8. Advanced clinical T category and high tumor grade independently predict worse survival among rectal cancer patients undergoing organ preservation

  Thursday, March 5, 2026
  10:00 AM - 10:30 AM MST

• QS15. Tumor-responsive natural killer cells infiltrate peritoneal metastasis from appendiceal adenocarcinoma

  Thursday, March 5, 2026
  10:15 AM - 10:19 AM MST

• TIP3. A prospective feasibility study using preoperative ctDNA to tailor neoadjuvant chemotherapy for patients with colorectal or appendiceal adenocarcinoma

  Friday, March 6, 2026
  3:55 PM - 3:59 PM MST

• TIP6. Metronidazole to optimize the microbiome of patients with rectal adenocarcinoma undergoing neoadjuvant therapy: protocol for the phase II MONARCH trial

  Friday, March 6, 2026
  3:51 PM - 3:55 PM MST